Cancer HealthCast: New Technologies Lead to Major Breakthroughs in Cancer Detection, Screening at NCI
Two key programs are playing a vital role in detecting and diagnosing cancer as well as reducing the overall burden on patients and their families.
The National Cancer Institute is utilizing a host of new technologies to diagnose and detect cancer thanks to its Innovative Molecular Analysis Technologies (IMAT) and Informatics Technology for Cancer Research (ITCR) programs. These programs are developing methods that are enhancing cancer research, including artificial intelligence.
Dr. Kelly Crotty, program director for NCI’s Center for Strategic Scientific Initiatives, said not only have the programs helped researchers better identify and screen for cancer, but also they’ve been instrumental in driving progress in clinical care. Crotty also shares updates about NCI’s Liquid Biopsy Consortium and discusses the benefits and challenges she’s seeing with AI.
-
Dr. Kelly Crotty Program Director, Center for Strategic Scientific Initiatives NCI
-
HHS Accelerates AI, TEFCA in 2024
Micky Tripathi, tech policy and health IT leader, reflects on progress HHS has made with AI, data and TEFCA and outlines plans for 2025.
-
Library of Congress, NARA Modernize Records Management with Emerging Tech
Natalie Buda Smith and Jill Reilly dive into the challenges of preserving and providing access to digital-native materials.
19m listen -
Trump's Return to Office Sparks Focus on AI Infrastructure
A potential AI czar and prior AI executive orders lead to new considerations for R&D and energy infrastructure.
7m read -
VA Focuses on Continuous Improvement for 2026 EHR Rollout
VA plans to resume rollout of its EHR in mid-2026, focusing recent feedback to drive continuous improvement amid the presidential transition.
4m read
